Oncology

#Oncology #Women's health

New fund now open to female breast and gynaecologic cancer investigators 

The AACR has announced a new funding opportunity in collaboration with Victoria’s Secret and Pelotonia.  The fund is for female investigators researching breast and gynaecologic cancers that focus on prevention, detection, diagnostic, and treatment innovations for breast and gynaecologic cancers and advancing outcomes for cancer health disparities. Read More

#News

Vitamin supplements
#Cancer research #Immunotherapy #Melanoma #Oncology #Skin cancer

Vitamin D levels impact response to immunotherapy in melanoma

New research indicates that for patients with advanced skin cancer, it may be important to maintain normal vitamin D levels when receiving treatment with immune checkpoint inhibitors. The findings are published in CANCER, a peer-reviewed journal of the American Cancer Society. Vitamin D has… Read More

#Cancer Research #News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

This week in drug discovery (24-28 April)

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to… Read More

#News

Genome editing
#Cancer research #Genetics / genomics #Immunotherapy #LambdaGen #Oncology #Partnership #Plasticell

UK-Singapore alliance focuses on cellular immunotherapy

UK company Plasticell and Singapore-based LambdaGen have entered into a strategic collaboration to exploit genome editing technologies based on synthetic lambda integrases that allow specific insertion of large gene cassettes into the human genome. The UK-Singapore partnership is in part financed by a EUREKA GlobalStars competitive… Read More

#News

T cells
#Cancer immunotherapy #Cancer research #Cell therapy #Immunotherapy #Oncology #Personalised medicine #Webinar

Learn about cancer immunotherapy in this webinar

Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ will be free to attend on May 10 at 8AM PST | 11AM EST | 4PM BST | 5PM CET.   Join this free webinar to… Read More

Webinar date:
Brought to you by BPS BioScience and AcroBiosystems
#News

Natural killer cells
#Cancer research #Icahn School of Medicine #Lung cancer #Macrophages #Oncology #Preclinical investigations

Macrophages suppress natural killer cells in lung cancer tumours

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer. The strategy involves inhibiting the immune-system molecule TREM2 while enhancing natural killer cells. “Our… Read More

#Cancer Research #News

European Commission
#Cancer research #European Commission #Janssen #Oncology #Phase III trial #Prostate cancer

EU approval for dual action prostate cancer therapy

The European Commission (EC) has granted marketing authorisation for Akeega (niraparib and abiraterone acetate [AA]) for adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline and/or somatic). The drug is given in the form of a dual action tablet (DAT), with prednisone or prednisolone,… Read More

#News #Regulatory

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

New podcast episode: DDW Highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news stories dominating the headlines this week have been the breaking developments in cancer drug… Read More

#News

Next-generation sequencing
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group #Webinar

Free webinar today: How is NGS informing oncology drug discovery?

Join this free webinar to learn about the biggest challenges and opportunities facing the next-generation sequencing (NGS) oncology space. Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend at 7AM PST / 10AM EST… Read More

Webinar date:
Brought to you by Tecan
#News

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

This week in drug discovery (16-21 April)

News round-up for 16-21 April by DDW Digital Content Editor Diana Spencer. The news stories dominating the headlines this week have been the breaking developments in cancer drug discovery announced at the American Association of Cancer Research (AACR) Annual Meeting, which was held in Florida, US… Read More

#News

Cancer immunotherapy
#Cancer immunotherapy #Cancer research #Cell therapy #Immunotherapy #Oncology #Personalised medicine #Webinar

Webinar on the future opportunities for cancer immunotherapy

Hosted by DDW and supported by BPS BioScience and ACROBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ will be free to attend on May 10 at 8AM PST | 11AM EST | 4PM BST | 5PM CET.   Join this free webinar to… Read More

Webinar date:
Brought to you by BPS BioScience and AcroBiosystems
#News

Cancer immunotherapy
#Cancer immunotherapy #Cancer research #Cell therapy #Immunotherapy #Oncology #Personalised medicine

Cancer immunotherapy – where will the future opportunities be?

Watch this free webinar to learn about the biggest opportunities for the future of cancer immunotherapy.   In this free webinar, you will hear from immunologist Dr Frédéric Triebel, CSO and CMO of Immutep, two experts from DeciBio: Dr Carl Schoellhammer, Principal, and Dr Joe Daccache, Senior Life… Read More

Webinar date:
Brought to you by BPS BioScience and AcroBiosystems
#Webinars

T cells attack cancer cell
#AACR 2023 #Cancer research #Melanoma #Oncology #Purple Biotech #Tumour microenvironment (TME)

New drug could help overcome tumour resistance to treatment

New study results have demonstrated the potential of a new drug to reprogramme the immune profile in the tumour microenvironment (TME) and convert resistant tumours to responders to Immune Checkpoint Blockage (ICB) therapies. Purple Biotech shared the new results at the American Association for Cancer Research… Read More

#Cancer Research #News

Leukaemia
#AACR 2023 #Blood cancer #Cancer research #Human disease models #Oncology

Unique new models will empower leukaemia research

Tisch Cancer Center scientists have developed unique models of acute myeloid leukaemia (AML), creating a transformative resource to study this cancer and eventually its drug response and drug resistance. The research was presented at the annual meeting of the American Association of Cancer Research and simultaneously… Read More

#Cancer Research #News